Home > News > Questioning Jim Cramer On The Merits Of ETFs
February 12th, 2007
Questioning Jim Cramer On The Merits Of ETFs
Abstract:
With regard to the idea of "anti-diversification", Cramer's talking about the new wave of ETFs that are highly focused in a sector like nanotechnology or a certain area of healthcare (cancer drugs for example). No doubt he's got a point there. But, his example of 5 stocks (Microsoft, Marvell, HP, CA, Merck) versus an ETF is unclear. I suppose what Cramer is saying is that whether you choose a few tech stocks or one of the newer, highly niche sector ETFs, in both cases you're not getting diversification. That's true and I'm betting that anyone who implements in any of these two ways is consciously and purposely making a bet in that sector. The question is if you want to make a bet in a specific sector, do you go with some direct stock picks or a sector fund/ETF? To each his own, but not everyone is a pro with the resources (especially time) to make a precise decision. This is just one of the many reasons for the ETF.
Source:
seekingalpha.com
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Leading the charge to better batteries February 28th, 2025
Quantum interference in molecule-surface collisions February 28th, 2025
New ocelot chip makes strides in quantum computing: Based on "cat qubits," the technology provides a new way to reduce quantum errors February 28th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||